C
Veracyte, Inc. VCYT
$46.16 -$0.23-0.50% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 427.11% 148.73% 148.48% 132.44% 81.45%
Total Depreciation and Amortization -4.98% -8.02% -11.02% -13.72% -14.11%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 0.00% -35.17% -51.04% -48.94% 0.89%
Change in Net Operating Assets 23.66% -7.57% 16.09% -412.11% -162.06%
Cash from Operations 63.70% 85.68% 138.92% 69.82% 72.14%
Capital Expenditure -4.10% 7.01% 1.17% -13.31% -3.29%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -100.00% -100.00% -100.00% -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -299.42% -100.00%
Cash from Investing -1,150.70% -1,988.71% -1,722.18% -472.39% 47.52%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -25.21% 138.87% 132.90% 108.74% 92.44%
Repurchase of Common Stock -112.26% -98.50% -95.37% -57.08% -37.45%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -185.33% -959.17% -348.61% 72.86% 340.22%
Foreign Exchange rate Adjustments 11.68% 900.00% -4,940.00% -360.12% -54.18%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -41.45% -135.24% -171.15% -62.62% 121.19%